A
Acurx Pharmaceuticals, Inc. (ACXP)
NCM – Real vaqt narxi. Valyuta: USD
2.05
-0.13 (-5.96%)
Yopilishda: May 12, 2026, 4:00 PM EDT
2.00
-0.05 (-2.44%)
Bozor oldidan: May 13, 2026, 8:03 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
2.05
-0.13 (-5.96%)
Yopilishda: May 12, 2026, 4:00 PM EDT
2.00
-0.05 (-2.44%)
Bozor oldidan: May 13, 2026, 8:03 AM EDT
Acurx Pharmaceuticals, Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, Qo'shma Shtatlarda bakterial infektsiyalarni davolash uchun antibiotiklar ishlab chiqadi. Kompaniyaning yetakchi antibiotik nomzodi ibezapolstat bo'lib, u polimeraza IIIC fermentini nishonga olgan yangi ta'sir mexanizmiga ega bo'lib, u clostridium difficile infektsiyalari bilan og'rigan bemorlarni davolash uchun 2b bosqichli klinik sinovdan o'tmoqda. U, shuningdek, metitsillinga chidamli stafilokokk aureus (MRSA), vancomitsinga chidamli enterokokki (VRE) va preparatlarga chidamli pnevmokokk (DRSP), shuningdek, B. anthracis kabi gramm-musbat bakteriyalarni davolash uchun potentsial og'iz orqali va parenteral davolash bo'lgan ACX-375Cni ishlab chiqadi. Acurx Pharmaceuticals, Inc. 2017 yilda tashkil etilgan va Nyu-Yorkning Staten orolida joylashgan.
| Ism | Lavozim |
|---|---|
| Mr. Robert J. DeLuccia | Co-Founder & Executive Chairman |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-11 | 10-Q | acxp-20260331x10q.htm |
| 2026-05-04 | S-1 | tm2611792d2_s1.htm |
| 2026-04-29 | D | |
| 2026-04-16 | 8-K | tm2611957d1_8k.htm |
| 2026-03-12 | S-8 | tm267891d1_s8.htm |
| 2026-03-09 | 8-K | tm268319d1_8k.htm |
| 2026-02-02 | S-1 | tm264593-1_s1.htm |
| 2025-12-30 | S-3/A | tm2534261d1_s3a.htm |
| 2025-11-12 | 10-Q | acxp-20250930x10q.htm |
| 2025-10-20 | S-1 | tm2528937d1_s1.htm |